Mobile Site ›
Print Page Email Page
Print Friendly View

Test ID: MENKM    
Multiple Endocrine Neoplasia Type 2 (2A, 2B, FMTC) Known Mutation

Secondary ID A test code used for billing and in test definitions created prior to November 2011

81082

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Screening of at-risk individuals when a mutation in the RET proto-oncogene has been identified in an affected family member

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

Documentation of the specific familial mutation must be provided with the specimen in order to perform this test.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase chain reaction (PCR) amplification/DNA sequencing are utilized to test for the presence of a specific mutation previously identified in an affected family member.
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

MEN2 (2A,2B,FMTC) Known Mutation

Aliases Lists additional common names for a test, as an aid in searching

Endocrine Cancer Syndrome
Familial Medullary Thyroid Cancer
FMTC
MEN 2A
MEN 2B
Multiple Endocrine Neoplasia type 2A
Multiple Endocrine Neoplasia type 2B
RET proto-oncogene (see Q&A for more info)